New Hampshire Plans of Safe and
Supportive Care — a Legal Primer
Fostering Services and Supports for Families when a
Baby is Born Exposed to Substances
Judges, attorneys, GALs, CASA volunteers, and other advocates and staff involved in the family
courts will find it helpful to understand prenatal opioid exposure, the state’s approach to Plans of
Safe Care, NH hospitals’ best practice treatment of exposed newborns, and relevant state and federal
laws, as a means to inform family engagement, shape referral to services and supports, and improve
outcomes for both infants and mothers.

Plans of Safe Care
Consistent with related federal law requirements, New Hampshire law requires the development of
a Plan of Safe Care (POSC), sometimes also called a Plan of Supportive Care by care providers,
“[w]hen an infant is born with and identified as being affected by substance abuse or withdrawal
symptoms resulting from prenatal drug exposure or a fetal alcohol spectrum disorder.”1 A POSC
fosters coordination of services and supports to help mothers and their infants stay safe and
connected to services when they leave the hospital. The POSC is developed collaboratively with the
mother and other caregivers to identify and reinforce existing strengths and supports, and to
coordinate referrals to new services. Ideally the POSC is developed prenatally, and should continue
to support the mother, baby and family after hospital discharge and during the early period of the
baby’s life. New Hampshire POSC tools and resources were developed by a multi-disciplinary
Perinatal Substance Exposure Task Force of the Governor’s Commission on Alcohol and other Drugs;
more details are available on the POSC webpage.
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Prenatal Drug Exposure and NAS

Reducing Stigma3

When pregnant women use drugs, their infants may be affected
and may display withdrawal symptoms. Neonatal abstinence
syndrome (NAS) is a common term used to refer to a cluster
of symptoms typically associated with opioid withdrawal in
newborns. Although some babies born exposed may not
demonstrate these symptoms, NAS can include tremors,
problems eating and/or sleeping, diarrhea, inconsolability,
fussiness, poor weight gain, and vomiting. Onset of symptoms
usually begins within one to two days of birth. Without
medication, these symptoms typically resolve within 1-2 weeks,
and can usually be managed in a non-intensive care setting.
The practice now followed by most NH hospitals calls for
nonpharmacological interventions as the best approach for
most of these infants, including supporting the mother or other
caregiver in providing skin-to-skin contact, swaddling, gentle
rocking, and a low stimulation environment.

“Research has identified the
stigma around NAS and substance
use disorders in general as a
significant barrier to treatment for
pregnant women. Many mothers
do not self-disclose their drug use
during pregnancy due to stigma,
complicating the treatment
process. In addition, when they
do reach out for help, ‘they often
encounter misinformation, denial,
inaction, and even judgmental
and punitive attitudes toward
their substance use.’ In some cases,
policies that initiate punitive
responses to pregnant women
with substance use disorders may
also create barriers to treatment.

Several important notes:
•

It is never correct to say that a baby is “born addicted,” as
addiction refers to “a treatable, chronic medical disease
involving complex interactions among brain circuits,
genetics, the environment, and an individual’s life
experiences,”2 as distinct from physical dependence and
withdrawal, which is what infants experience.

•

The existence, severity and duration of NAS symptoms are
clinical indicators that inform hospital care decisions, but
do not alone indicate parental abuse, neglect or unfitness;
indeed, NAS symptoms may occur because a pregnant
woman is taking prescribed medication as directed to
address chronic pain, or is in recovery from opioid use
disorder and maintained on buprenorphine or methadone,
as well as from using illicit substances such as heroin or
fentanyl.

•

Unlike alcohol, which is known to cause permanent physical,
cognitive and behavioral disabilities in infants exposed in
utero, there is little conclusive evidence regarding long-term
health effects as a result of opioid exposure. Referral for early
intervention and supports, as well as parental supports, can
help to ensure that these babies grow up without long term
deficits.
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In 2013, 40 leading medical
experts sent a letter to several
prominent news outlets describing
how sensationalized terminology
commonly used in the media
to describe NAS is medically
inaccurate and reinforces
stigma. Drug-addicted babies,
for example, is not an accurate
description of babies born with
NAS. These newborns may exhibit
physiologic dependence, but they
cannot exhibit the compulsive
behaviors associated with
addictive disorders. This language
is successful at eliciting a strong
emotional response, but may
also help to reinforce many of the
negative attitudes that discourage
women from accessing the
treatment they need.”
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Federal and State Laws
The Child Abuse Prevention and Treatment Act (CAPTA) is the primary federal statute addressing
child abuse and neglect. For many years, CAPTA has required that states address the needs of
infants born with prenatal substance exposure.4 In 2016, the Comprehensive Addiction and
Recovery Act (CARA) amended several provisions of CAPTA pertaining to the development of Plans
of Safe Care (POSC). In response to these amendments, the New Hampshire legislature enacted RSA
132:10-e and 132:10-f to establish the requirements for POSCs in this state, including a process for
notification of births, aggregated reporting, development of POSCs and referrals for services.
New Hampshire law requires a health care provider develop a POSC “[w]hen an infant is born
with and identified as being affected by substance abuse or withdrawal symptoms resulting from
prenatal drug exposure or a fetal alcohol spectrum disorder.”5 Although a POSC is not legally
required for all infants, all mothers deserve a plan of safe care, and developing one with all mothers
reduces stigma associated with the POSC and helps all infants and families stay safe and supported.

Developing and Sharing of Plans of Safe Care
All NH birthing hospitals are working to train staff and implement the POSC process, with the goal
of adopting more consistent practices to ensure that each mother who delivers a baby prenatally
exposed to substances leaves the hospital with a POSC for her newborn. The POSC must be given to
the mother or infant’s other caregiver upon discharge from the hospital or birth center.6 Providers
may encourage the mother to share the POSC with partners or close family or friends, as well as the
professionals who will be supporting her and her infant. This may include not only the mother’s
and infant’s other healthcare providers, but also, as relevant, home visiting services, family resource
centers, or other community agencies. Best practices call for the hospital to share the POSC with the
infant’s pediatrician. The POSC includes private health information that may, absent patient consent,
be protected from disclosure by health and substance use disorder record confidentiality laws.
To the extent the mother or caregiver is involved in a Drug Court program or is otherwise
interacting with the judicial system, the court may want to ask about the POSC, as a means to
understand what strengths and supports, as well as needs and gaps, have been identified for the
family. Knowledge of the POSC process and purposes may be important for those involved in
assisting mothers and families.

Reporting to DCYF
The POSC is not shared with DCYF unless a report of child abuse and/or neglect is made.7 The fact
that an infant is born with withdrawal symptoms, or prenatal exposure to drugs and/or alcohol
more broadly, does not itself constitute abuse or neglect of an infant nor require a mandatory
report. Furthermore, the fact that a provider develops a POSC with a mother does not necessarily
mean the provider has a reason to suspect child abuse or neglect. For example, an infant exposed
prenatally to drugs due to medication prescribed to the mother under a clinician’s direction and
without any child safety concerns does not need to be reported to DCYF. Some providers may
adopt the recommended practice of developing POSCs with all new mothers, not just those for
whom substance exposure is present. When a provider makes a mandated report to DCYF based on
concerns for risk of child abuse and/or neglect, the POSC must be shared with DCYF.8
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Distinguishing Plans of Safe Care and a DCYF Plan of Care
The federally required “Plan of Safe Care” created by providers with the mother and family is not to
be confused with a Safety, Case or Action Plan developed by DCYF for open abuse/neglect cases.
The name “Plan of Safe Care” comes from federal and state statute. The POSC document is designed
to support mothers as crucial partners in their babies’ care. A mother’s adherence to a POSC is
voluntary. The POSC is intended to be developed collaboratively and is not presented to the mother
by her care providers as a plan that must be followed to retain custody.
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